Opinion & analysis

Probiotic Safety Latest Target Of Supplement Regulation Critic Cohen

Probiotic labeling came under fire in a recent opinion piece published in JAMA Internal Medicine, which called for more detailed and extensive labeling for probiotic supplements, as well as improved good manufacturing practices (GMP) as they pertain to the production of products containing live microorganisms.

Probiotic Safety Latest Target Of Supplement Regulation Critic Cohen

ASCO 2018: Optimism As Industry Resets And Looks To What Is Next

Top 10 Drugs: Biologic Blockbusters And The Biosimilar Threat

From Device Centric To Disease Management: Ascensia Commits To Deeper Role In Diabetes

GSK Woes Raise Big Pharma R&D Question

Estee Lauder Is Revising Claims, Retesting Products After Internal Breakdown

How To Pay For The New Wave Of Gene Therapies

Father of Humira, Greg Winter, Wins 2018 Nobel Prize For Chemistry

GSK’s Hal Barron On R&D Progress At TwoYear Mark

Gene Therapy’s Next Big Challenge: Manufacturing

OTC Marketing Awards 2019 Winners Announced – GSK Crowned Company Of The Year, Pfizer’s Viagra Takes Best Brand

Patient-Specific Drive Takes Ortho Group Corin Into TKR Robotics With Omni Purchase

US FDA Commissioner: Agency Will Propose New Rule That Blends Quality System Regulation, ISO 13485

Mortality Signal For Pfizer’s Xeljanz In Rheumatoid Arthritis Puts A Damper On JAK Class

Novartis’ Zolgensma Had Manipulated Data In Application, US FDA Says